STAT Plus: Did FDA unfairly treat Catalyst by approving a similar drug from another company?
ANDREW HARNIK/AP
Legal experts suggest that if Catalyst goes to court, its lawyers may argue the company was not treated fairly under a federal law.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario